@CyberBiotech@Lopez Lets leave the silly squabbles on other forums/threads. MSB's poor history on display for all to see. If anyone gets an approval in an allogeneic stem cell therapy, MSB or otherwise, its undeniably going to buoy the whole stem cell sector. That the FDA has granted application to (and even approved a J&J) autologous cellular therapies has already improved the regulatory pathway probabilities for ATI for OCC. That would only do so further.
OCC Trading, page-1335
-
- There are more pages in this discussion • 393 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.5¢ |
Change
-0.005(1.25%) |
Mkt cap ! $82.68M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 40.0¢ | 39.0¢ | $65.71K | 166.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1052 | 39.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 354895 | 8 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| OCC (ASX) Chart |